Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest Microarrays Stories

2013-12-04 08:29:04

SAN DIEGO, Calif. and ST. OUEN L'AUMONE, France, Dec. 4, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced that Laboratoire Cerba has launched its validated noninvasive prenatal test (NIPT) to health care providers and their patients in France, Belgium, Luxembourg and portions of the Middle East and Africa. Laboratoire Cerba's test utilizes patented technology licensed from Sequenom to...

2013-12-03 23:20:49

This research report categorizes the Global DNA & Gene Chip (microarray) market on the basis of applications, types, and geography; forecasting revenues and analyzing trends. http://www.marketsandmarkets.com/Market-Reports/genechips-367.html (PRWEB) December 03, 2013 The “Global DNA and Gene Chip (Microarrays) Market (2010 - 2015)”, analyzes the DNA microarray market by types and applications and studies the major market drivers, restraints, opportunities, and market trends for...

2013-12-03 08:31:51

SAN DIEGO, Dec. 3, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the Oppenheimer 24th Annual Healthcare Conference at the Crowne Plaza Hotel in New York, NY on December 10-11, 2013. William Welch, President and COO, Paul V. Maier, Chief Financial Officer and Ronald M. Lindsay, Ph.D., EVP Strategic Planning, will present on Tuesday,...

2013-11-21 12:27:59

DUBLIN, Ireland, November 21, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/r28v8x/molecular) has announced the addition of the "Molecular Diagnostics in Cancer Testing" [http://www.researchandmarkets.com/research/r28v8x/molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and...

2013-11-21 08:26:54

SAN DIEGO, Nov. 21, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the Piper Jaffray 25th Annual Health Care Conference at the New York Palace Hotel in New York, NY on December 3-4, 2013. William Welch, President and COO, Paul V. Maier, Chief Financial Officer and Ronald M. Lindsay, Ph.D., EVP Strategic Planning, will present on...

2013-11-20 12:28:34

DUBLIN, November 20, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/84xb3g/microarray_markets) has announced the addition of the "Microarray Markets" [http://www.researchandmarkets.com/research/84xb3g/microarray_markets ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Microarray technologies multiplex and miniaturize the analysis of tens of thousands of molecules for a variety of...

2013-11-15 23:20:23

In 2005, the launch of next-generation sequencing technologies radically changed the structure of the biotechnology industry. Since then, the costs of sequencing have rapidly reduced to the point where it is now feasible for complex NGS tests to be priced in the range of other multiplex genetic tests and pave the way for new opportunities in clinical applications. Wellesley, Mass (PRWEB) November 15, 2013 In 2005, the launch of next-generation sequencing technologies radically changed the...

2013-11-07 23:03:39

Reportbuyer.com just published a new market research report: Molecular Biomarkers for Cancer Detection and Management. London (PRWEB) November 07, 2013 New to Insight Pharma Reports is Molecular Biomarkers for Cancer Detection and Management: Technologies, Markets, and Trends. This report focuses on recent progress and new directions in this highly dynamic diagnostic field. Covering extensive background and history, commercialization, and marketing trends of cancer biomarker technologies,...

2013-11-07 16:31:43

Announces Record Revenue for the Quarter SAN DIEGO, Nov. 7, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today reported total revenues of $44.0 million for the third quarter of 2013, an increase of 26% compared to revenues of $34.9 million for the second quarter of 2013, and an increase of 92% compared to revenues of $22.9 million for the third quarter of 2012. "We are proud to report...

2013-11-05 16:26:36

DUBLIN, November 5, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/66tsj8/analysis_of) has announced the addition of the "Analysis of Global Biochips Industry, 2012-2018" [http://www.researchandmarkets.com/research/66tsj8/analysis_of ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Global biochips market is forecasted to reach US$11.4 billion by 2018 with a CAGR of 18.6% during...